Markets
BUSINESS NEWS
- Market News
- Earnings
- Recalls
- Recession Watch
- Tech News
- Financial Crisis
- Madoff Scandal
- BloggingStocks
- Luxist
- Money Videos
INVESTING
- Stock Quotes
- Stock Charts
- Stock Ticker
- Currencies
- Portfolio
- Stock Screener
- Broker Center
- Mutual Fund Center
- ETF Center
- Money
- 24/7 Wall St.
- Financial Glossary
PERSONAL FINANCE AT WALLETPOP
- Bargains
- Banking
- Budget
- Calculators
- College Finance
- Community
- Credit
- Deals
- Debt
- Economizer
- Food
- Home
- Fraud
- Insurance
- Interest Rates
- Loans
- Mortgages
- Real Estate
- Recalls
- Recession
- Retirement
- Saving
- Simplification
- Specials
- Taxes
SMALL BUSINESS
Church&Dwight 3Q profit up on legal settlement
PRINCETON, N.J. (AP) — Church&Dwight Co., which makes OxiClean and other consumer poroducts, said Tuesday that its profit surged in the third quarter, helped by a favorable legal settlement and strong sales of some of its brands.
The company boosted its full-year earnings guidance, citing its solid year-to-date performance.
Chairman and CEO James Craigie said in a statement that shoppers were attracted to its value-oriented products and new products, with results also benefiting from higher prices implemented last year.
Some brands that recorded increased sales during the quarter included Arm&Hammer liquid laundry detergent, Oxiclean laundry additive, Trojan and Spinbrush.
Church&Dwight earned $70 million, or 98 cents per share, for the three months ended Sept. 25. That's up 43 percent from $49 million, or 69 cents per share, a year ago.
Excluding a favorable legal settlement of 17 cents per share and a plant restructuring charge, profit was 86 cents per share.
Analysts surveyed by Thomson Reuters, whose estimates normally exclude one-time items, predicted earnings of 83 cents per share.
Revenue climbed 3 percent to $646.2 million from $630.7 million, which topped Wall Street's estimate of $642.3 million.
Church&Dwight raised its 2009 profit forecast to a range of $3.40 to $3.43 per share, up from a prior outlook of $3.35 to $3.40 per share. The guidance excludes plant restructuring charges and the legal settlement.
Analysts expect full-year earnings of $3.43 per share.